Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial.

Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med. 2013 Jul 16; 159(2):77-85.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.